Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189
Open Access
- 6 September 2019
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 68 (11), 2143-2154
- https://doi.org/10.2337/db19-0271
Abstract
While peripheral neuropathy is the most common complication of long-term diabetes, cognitive deficits associated with encephalopathy and myelopathy also occur. Diabetes is a risk factor for Alzheimer disease (AD) and increases the risk of progression from mild cognitive impairment to AD. The only current recommendation for preventing or slowing the progression of peripheral neuropathy is to maintain close glycemic control, while there is no recommendation for central nervous system disorders. NSI-189 is a new chemical entity that when orally administered promotes neurogenesis in the adult hippocampus, increases hippocampal volume, enhances synaptic plasticity, and reduces cognitive dysfunction. To establish the potential for impact on peripheral neuropathy, we first showed that NSI-189 enhances neurite outgrowth and mitochondrial functions in cultured adult rat primary sensory neurons. Oral delivery of NSI-189 to murine models of type 1 (female) and type 2 (male) diabetes prevented multiple functional and structural indices of small and large fiber peripheral neuropathy, increased hippocampal neurogenesis, synaptic markers and volume, and protected long-term memory. NSI-189 also halted progression of established peripheral and central neuropathy. NSI-189, which is currently in clinical trials for treatment of major depressive disorder, offers the opportunity for the development of a single therapeutic agent against multiple indices of central and peripheral neuropathy.Keywords
Funding Information
- National Institute on Aging (AG-039736)
- National Institute of Neurological Disorders and Stroke (1R44-NS-103703)
- National Institute of Diabetes and Digestive and Kidney Diseases (NS-081082)
This publication has 50 references indexed in Scilit:
- Encephalopathies: the emerging diabetic complicationsActa Diabetologica, 2010
- Progression of Cerebral Atrophy and White Matter Hyperintensities in Patients With Type 2 DiabetesDiabetes Care, 2010
- Risk of developing dementia in people with diabetes and mild cognitive impairmentThe British Journal of Psychiatry, 2010
- Distinct roles for dorsal CA3 and CA1 in memory for sequential nonspatial eventsLearning & Memory, 2009
- The Roles of Streptozotocin Neurotoxicity and Neutral Endopeptidase in Murine Experimental Diabetic NeuropathyExperimental Diabetes Research, 2009
- Defective insulin signaling pathway and increased glycogen synthase kinase‐3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulinJournal of Neuroscience Research, 2008
- Differential roles for hippocampal areas CA1 and CA3 in the contextual encoding and retrieval of extinguished fearLearning & Memory, 2008
- Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neuronsNature Neuroscience, 2008
- Brain Magnetic Resonance Imaging Correlates of Impaired Cognition in Patients With Type 2 DiabetesDiabetes, 2006
- Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neuronesBrain Research, 1993